Filing Details

Accession Number:
0001237648-17-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-09 14:11:05
Reporting Period:
2017-03-09
Filing Date:
2017-03-09
Accepted Time:
2017-03-09 14:11:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1038133 Heska Corp HSKA Biological Products, (No Disgnostic Substances) (2836) 770192527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1499911 John Mcmahon 3760 Rocky Mountain Avenue
Loveland CO 80538
Vp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-09 125 $28.39 200 No 4 M Direct
Common Stock Disposition 2017-03-09 125 $97.42 75 No 4 S Direct
Common Stock Acquisiton 2017-03-09 583 $39.76 658 No 4 M Direct
Common Stock Disposition 2017-03-09 583 $97.42 75 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2017-03-09 125 $0.00 125 $28.39
Common Stock Incentive Stock Option (right to buy) Disposition 2017-03-09 583 $0.00 583 $39.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,334 2015-10-14 2025-10-13 No 4 M Direct
4,959 2015-12-29 2025-12-28 No 4 M Direct